Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 02. März 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7880  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 157583  
   
Cancer-associated fibroblasts in non-small cell lung cancer therapy: Challenges and opportunities.
Biochim Biophys Acta Rev Cancer
Deng S, Li Y, Peng L, Li J, Zhang L.
PMID: 41765207 [PubMed - as supplied by publisher]


Predictors of Bronchopleural Fistula After Percutaneous Microwave Ablation of Lung Tumors.
J Vasc Interv Radiol
Zhong JS, Chen J, Lin ZY.
PMID: 41765081 [PubMed - as supplied by publisher]


Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional - prospective study to inform referral for germline testing.
Lung Cancer
Citarella F, Venanzi FM, Di Giovanni G, Takada K, Cascetta P, Crucitti P, Lintas C, Fiorenti M, Mingo EC, La Cava G, Russano M, Pantano F, Vincenzi B, Tonini G, Vavalà T, Milanesi E, Oresti S, Crinò L, Delmonte A, Ferrara R, Di Maio M, Gurrieri F, Cortellini A.
PMID: 41764946 [PubMed - as supplied by publisher]


Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study.
Lung Cancer
Toda M, Takada K, Nomura K, Kosai K, Hayasaka K, Watanabe T, Takamori S, Hamada A, Suda K, Ohara S, Ito M, Oiki H, Fukami T, Muto S, Katsumata S, Konno H, Toyoda T, Endo M, Takamori S, Nakatsuka M, Tenpaku H, Takegahara K, Matsubara T, Kinoshita F, Akamine T, Nakamura R, Mizuno K, Nakagawa K, Kaneda S, Okada S, Notsuda H, Sakane T, Shinohara S, Abe M, Haratake N, Tane S, Hanawa R, Ito A, Namba K, Kawaguchi T, Minegishi K, Kurihara N, Iguchi T, Aokage K, Tsuboi M, Iwata T, Soh J, Shimokawa M, Ohde Y.
PMID: 41764944 [PubMed - as supplied by publisher]


Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial).
J Transl Med
Piedra A, Guinart-Cuadra A, Martínez-Recio S, Mulet M, Zamora C, Osuna-Gómez R, Cantó E, Ortiz MA, Alejandre J, Barba A, Sanz-Beltrán J, Serra-López J, Isla D, Arriola E, Paz-Ares L, Diz-Taín MP, Moreno AL, Callejo Á, Vidal S, Majem M.
PMID: 41764558 [PubMed - as supplied by publisher]


Diagnostic Utility of Expression Imbalance in Idylla GeneFusion Assay for Non-Small Cell Lung Cancer.
J Mol Diagn
Stram MN, Caffes PL, Lo YC.
PMID: 41763606 [PubMed - as supplied by publisher]


Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies.
Cancer Lett
Yan JS, Wang YZ, Zhao SY, Na FJ, Cui ZX, Cai LT, Li HM, Zhao MF.
PMID: 41763450 [PubMed - as supplied by publisher]


Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trial.
Thromb Res
Sato T, Ogihara Y, Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, Nishimoto Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Tsukahara K, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Ono K, Kimura T, Dohi K, ONCO PE Trial Investigators.
PMID: 41762931 [PubMed - as supplied by publisher]


The effectiveness of the AI-based RehabLung mobile rehabilitation system on cardiopulmonary function and user satisfaction in lung cancer patients undergoing thoracic surgery: a protocol for a two-arm randomized clinical trial.
Ther Adv Respir Dis
Yang HL, Hung CH, Huang YT, Cheng HC, Tseng YL, Su JM, Tsai KL.
PMID: 41762649 [PubMed - in process]


Integrating network pharmacology and Mendelian randomization to explore potential targets of Fufang Banmao capsule against non-small cell lung cancer.
Pak J Pharm Sci
Wei Z, Hu Y, Zuo F, Liu C, Wu D, Sun X.
PMID: 41761800 [PubMed - in process]


Triangulating Associations Between Fruit Intake and Lung Cancer Risk: Evidence from GBD Estimates, Mendelian Randomization, and Real-World Validation.
Oncologist
Liu M, Hu Q, Zhang X, Wu Z, Wang S, Hu Y, Xu S, Xu Z, Luo J, Sun L.
PMID: 41761571 [PubMed - as supplied by publisher]


Dacomitinib as a First-Line Therapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational Study.
Cancer Med
Hsu PC, Ko HW, Chiu LC, Huang SH, Lee CS, Lin YC, Kuo SC, Ju JS, Wang CC, Yang CT.
PMID: 41761381 [PubMed - in process]


Feasibility and preliminary efficacy of an art-making program to manage fear of cancer recurrence (AM-I-FCR) in lung cancer patients: a randomized controlled pilot study.
BMC Med
Lin J, Kang Z, Zhang C, Arbing R, Chen WT, Huang F.
PMID: 41761252 [PubMed - as supplied by publisher]


Efficacy and tolerability of first-line treatment regimens for extensive-stage small cell lung cancer - a grade-assessed network meta-analysis of randomized controlled trials.
BMC Cancer
Najah Q, Makhlouf HA, Osman ASA, Almosilhy NA, Abusalah MA, Abuhlaiga MA, Qutob IA, Abdelgawad HAH.
PMID: 41761164 [PubMed - as supplied by publisher]


SLC and ABC Transporters in Lung Cancer: Orchestrators of Malignancy and Therapeutic Resistance.
Compr Physiol
Li P, Dong M, Chen B, Luo J, Jiang H, Lin N.
PMID: 41761042 [PubMed - in process]


Efficacy and safety of tepotinib in MET‑altered non‑small cell lung cancer: a meta-analysis.
Sci Rep
Xiao J, Cai Q, Li X, Zhang D.
PMID: 41760894 [PubMed - as supplied by publisher]


Characterizing Risk Factors and Outcomes in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer Who Do Not Complete, or Who Experience Progression During/Within 42 Days of, Concurrent Chemoradiotherapy: The POSITION Study.
Clin Lung Cancer
Mountzios G, Weng JK, Zairi E, Hsieh K, Chander P, Dunlop W, Qiao Y, Wang A, Januszewski A.
PMID: 41760536 [PubMed - as supplied by publisher]


ScRNA-Seq: A way to reveal the potential mechanisms of metastasis in small cell lung cancer.
Bull Cancer
Guan XL, Gan DX, Wu Y, Zhang Y.
PMID: 41760455 [PubMed - as supplied by publisher]


History of Chronic Obstructive Pulmonary Disease May Contribute to Earlier Diagnosis of Lung Cancer.
In Vivo
Marel M, Domecky P, Fernando CML, Bejckova A, Fila L, Hrnciarik M, Vencalek T, Roubec J, Duba J, Svaton M.
PMID: 41760320 [PubMed - in process]


Mechanistic Studies of Anticancer Effects of Salicylaldehyde Benzoylhydrazone in 2D/3D Lung Cancer Cell Cultures.
Anticancer Res
Sangseekew W, Boonsombat J, Thongnest S, Sirirak J, Sornprachum T, Lirdprapamongkol K, Svasti J, Ruchirawat S, Keeratichamroen S.
PMID: 41760238 [PubMed - in process]


   
   Artikel 1 - 20 / 157583    Seite 1 von 7880  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1